NM_030809.3(CSRNP2):c.1288G>A (p.Val430Met) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 6, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003012615.8

Allele description [Variation Report for NM_030809.3(CSRNP2):c.1288G>A (p.Val430Met)]

NM_030809.3(CSRNP2):c.1288G>A (p.Val430Met)

Genes:

LETMD1:LETM1 domain containing 1 [Gene - OMIM - HGNC]
CSRNP2:cysteine and serine rich nuclear protein 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12q13.12

Genomic location:

Preferred name:

NM_030809.3(CSRNP2):c.1288G>A (p.Val430Met)

HGVS:

NC_000012.12:g.51064090C>T
NG_029858.2:g.20871C>T
NG_029858.3:g.20872C>T
NM_001351337.2:c.544-3172C>T
NM_030809.3:c.1288G>AMANE SELECT
NP_110436.1:p.Val430Met
NC_000012.11:g.51457873C>T
NM_030809.2:c.1288G>A
NR_045072.2:n.1742G>A

Protein change:

V430M

Molecular consequence:

NM_001351337.2:c.544-3172C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_030809.3:c.1288G>A - missense variant - [Sequence Ontology: SO:0001583]
NR_045072.2:n.1742G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Observations:

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003722616	Ambry Genetics	criteria provided, single submitter (Ambry General Variant Classification Scheme_2022)	Uncertain significance (Oct 6, 2021)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003722616

Ambry Genetics

criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)

Uncertain significance
(Oct 6, 2021)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	1	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003722616.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

The c.1288G>A (p.V430M) alteration is located in exon 5 (coding exon 4) of the CSRNP2 gene. This alteration results from a G to A substitution at nucleotide position 1288, causing the valine (V) at amino acid position 430 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Apr 20, 2024

ClinVar

Relating variation to medicine